September 9, 2026 · earnings
SCNI earnings: a neutral outcome, +0.6%
On September 9, 2026, Scinai Immunotherapeutics Ltd. reached its earnings. The result was a neutral outcome, and the stock moved +0.6% in the window around the event. It had already run -25.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$1.70
1d before
$1.71
Event day
$1.67
1d after
$2.44
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+3.2% expected); the stock actually moved +0.6%. Model confidence at the time: 44%.
See the full scored track recordPre-catalyst setup
-25.9%
30-day run-up
11337%
30-day volatility
0.7×
volume spike